• Accelerating TB vaccine Research & Development through partnership
    • TBVI TBVI TBVI
    • Home
    • About us
      • TBVI at a glance
      • Mission
      • Organisation
        • Governance Board
        • Advisory Committee
        • Research & Innovation group
        • Operational Office
        • Product and Clinical Development Team
        • Portfolio Management Committee
      • TBVI consortium
      • Key achievements and impact
      • Financials
    • What we do
      • Pipeline of vaccines
      • Research & Development
      • Services
    • How we work
      • Business model
      • Partnership
    • For partners
      • For researchers and vaccine developers
        • Partners pages
        • Become a TBVI partner
        • Access to services
        • Conferences, meetings and workshops
      • TBVAC2020
        • Word from the chair
        • TBVAC2020 project description
        • TBVAC2020 project members
        • TBVAC2020 scientific publications
        • TBVAC2020 developments
      • MTBVAC in Newborns
        • MTBVAC in newborns
        • Coordinator and partners
        • News and Publications
        • Communication tools
      • For funders
        • TBVI R&D priorities and funding opportunities
        • 2015-2017 TBVI service provision and funding opportunities
        • Why invest in TBVI
    • News
    • Contact us:

    Operational Office

    Home / About us / Organisation / Operational Office
    • Dr Nick Drager
      Dr Nick DragerExecutive Director
    • Dr Jelle Thole
      Dr Jelle TholeSr. Advisor Vaccine Development
    • Cora Agterdenbosch
      Cora AgterdenboschSr. Management Assistent
    • René Coppens MSc
      René Coppens MScDirector External Relations & Resource Mobilisation
    • Koen de Lange
      Koen de LangeGeneral Legal Counsel
    • Anne Meinema MSc
      Anne Meinema MScDirector Finance and Administration
    • Danielle Roordink MSc
      Danielle Roordink MScSr. Project Manager
    • Marit Holleman MSc
      Marit Holleman MScKnowledge exchange and networking manager
    • Dr Gerald Voss
      Dr Gerald VossScientific Director
    Menu
    • Home
    • About us
    • What we do
    • How we work
    • For researchers and vaccine developers
    • For funders
    • Pipeline of vaccines
    • News
    TuBerculosis Vaccine Initiative (TBVI)

    Runderweg 6
    8219 PK Lelystad
    The Netherlands
    Email: info@tbvi.eu
    Phone: +31 320 277 550

    © 2015 TuBerculosis Vaccine Initiative (TBVI) | ALL RIGHTS RESERVED | Disclaimer | Sitemap | Door Internetbureau Redkiwi

    Start typing and press Enter to search

    Cookies

    This website uses cookies that help the website function

    OK No